Navigation Links
NIEHS awards Recovery Act funds to focus more research on health and safety of nanomaterials
Date:11/19/2009

Elder and Gunter Oberdorster, University of Rochester, N.Y.
  • Andrij Holian, University of Montana, Missoula
  • Andre Elias Nel, University of California, Los Angeles
  • Galya Orr, Battelle Pacific Northwest Laboratories, Richland, Wash.
  • Christopher D. Vulpe, University of California, Berkeley
  • Paul K. Westerhoff, Arizona State University, Tempe
  • Frank A. Witzmann and Somenath Mitra, Indiana University, Indianapolis
  • Robert M. Worden, Michigan State University, East Lansing

    The three Recovery Act Nanotechnology NIH Challenge Grants have been awarded to:

    • Kent E. Pinkerton, University of California, Davis
    • Timothy R. Nurkiewicz, West Virginia University, Morgantown
    • Wynne K. Schiffer, Feinstein Institute for Medical Research, Morgantown, W.Va.

    The NIEHS also used Recovery Act funds to support efforts under its Superfund Research Program to determine ways to apply nanotechnology to better detect and evaluate effects on human health, and clean up Superfund chemicals in the environment. The Superfund Worker Education Training Program also provided Recovery Act funding targeting health and safety training.


    '/>"/>


  • Contact: Robin Mackar
    919-541-0073
    NIH/National Institute of Environmental Health Sciences
    Source:Eurekalert

    Page: 1 2 3 4

    Related biology news :

    1. NIEHS awards Recovery Act funds to address bisphenol A research gaps
    2. NIEHS invests $21.25 million to find environmental causes of Parkinsons disease
    3. Duke-NIEHS team shows how DNA repairs may reshape the genome
    4. NIH awards $8.5 million for research on pharmaceuticals for children
    5. Winners of the 2009 AAAS Kavli science journalism awards
    6. NCI awards $15.2 million to create Princeton Physical Sciences -- Oncology Center
    7. March of Dimes establishes 2 new perinatal bioethics awards
    8. NSF awards Life in Transition grants to University of Oklahoma professors
    9. New research examining essential drugs, emerging botanicals supported by USP Awards
    10. Research with wood ducks earns graduate student 2 national awards
    11. National Science Foundation awards grant to Oklahoma structural biology group
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/31/2014)... experimental vaccine protected 100 percent of animal models against ... , which causes an intestinal disease that kills approximately ... print in Infection and Immunity . , ... non-human primates against the purified toxins produced by ... spore infection, a laboratory model that mimics the human ...
    (Date:7/31/2014)... how the brain processes speech, potentially increasing the ... at The University of Texas at Dallas. , ... Ear and Hearing , researchers demonstrated for the ... brain,s recognition of speech sounds. , Noise-induced hearing ... affecting an estimated 15 percent of Americans between ...
    (Date:7/31/2014)... step has been made to help better identify and treat ... abnormal narrowing and enlarging of medium sized arteries in the ... other organs causing damage. In a new report appearing in ... , scientists provide evidence that that FMD may not be ... show a connection to abnormalities of bones and joints, as ...
    Breaking Biology News(10 mins):C. difficile vaccine proves safe, 100 percent effective in animal models 2UT Dallas study reveals effect of loud noises on brain 2Scientists discover biochemical mechanisms contributing to fibromuscular dysplasia 2
    ... farming and relieve the pressure on overexploited fish stocks. ... fish escape? Researchers at the University of Gothenburg have ... are urging caution:,-Until further notice transgenic fish should be ... at the Department of Zoology, University of Gothenburg. ...
    ... A research report featured on the cover of the September ... http://www.fasebj.org ) describes how Australian scientists developed a new gene ... to transport their cargo into our cells. As a result ... cell,s nucleus far more efficiently than in the past, raising ...
    ... from natural coal deposits in the Gulf of Alaska ... the Exxon Valdez tanker catastrophe. This clearly disproves the ... observed environmental damage. PAH pollutants were blamed for the ... Alaska. Then a dispute erupted over the origins of ...
    Cached Biology News:Risks involved with transgenic fish 2Finding the ZIP-code for gene therapy: Scientists imitate viruses to deliver therapeutic genes 2Bioavailable contaminants come from the Exxon Valdez oil catastrophe 2
    (Date:8/1/2014)... , Aug. 1, 2014 ... the "The World Market for Flow Cytometry ... http://photos.prnewswire.com/prnh/20130307/600769 ... that are now an important component of advanced ... diagnostic instruments for cancer diagnostics, but their newer ...
    (Date:8/1/2014)... 2014 The  PROPEL Center  of the  iBIO ... rate of early-stage life sciences companies in ... 15 grants to help Illinois ...   in Chicago .   AdvaMed ... North America , bringing more than 1,000 ...
    (Date:8/1/2014)... Cambrex Corporation (NYSE: CBM ) reports results for ... Highlights , Second quarter sales increased 59% to ... year. , Second quarter EBITDA increased 86% to $21.2 ... year (see table at the end of this release). ... of foreign currency, to between 13% and 16% over 2013, ...
    (Date:7/31/2014)... July 31, 2014 Today BioSpace , the leading life ... map campaign spotlighting the life sciences community in Illinois ... Kansas , Michigan , Minnesota ... Ohio and Wisconsin . ... percent of all job postings on BioSpace originating in this region in ...
    Breaking Biology Technology:The World Market for Flow Cytometry in IVD Applications 2iBIO Institute's PROPEL Center Awards Grants for AdvaMed 2014 to Early-Stage Life Sciences Companies 2iBIO Institute's PROPEL Center Awards Grants for AdvaMed 2014 to Early-Stage Life Sciences Companies 3iBIO Institute's PROPEL Center Awards Grants for AdvaMed 2014 to Early-Stage Life Sciences Companies 4Cambrex Reports Second Quarter 2014 Financial Results 2Cambrex Reports Second Quarter 2014 Financial Results 3Cambrex Reports Second Quarter 2014 Financial Results 4Cambrex Reports Second Quarter 2014 Financial Results 5Cambrex Reports Second Quarter 2014 Financial Results 6Cambrex Reports Second Quarter 2014 Financial Results 7Cambrex Reports Second Quarter 2014 Financial Results 8Cambrex Reports Second Quarter 2014 Financial Results 9Cambrex Reports Second Quarter 2014 Financial Results 10Cambrex Reports Second Quarter 2014 Financial Results 11Cambrex Reports Second Quarter 2014 Financial Results 12Cambrex Reports Second Quarter 2014 Financial Results 13Cambrex Reports Second Quarter 2014 Financial Results 14Cambrex Reports Second Quarter 2014 Financial Results 15Cambrex Reports Second Quarter 2014 Financial Results 16Midwest Biotech Leaders Featured On BioSpace Map 2
    ... China, July 7 /PRNewswire-Asia-FirstCall/ -- China Clean,Energy Inc. ... "Company"),a producer of biodiesel fuel and environmentally-friendly specialty ... Republic of China,("PRC"), today announced that business conditions ... the first quarter, driven by improved demand and,higher ...
    ... Lexicon Pharmaceuticals, Inc. (Nasdaq: ... developing breakthrough treatments for human disease, announced today that it ... LX1032 , the company,s oral drug candidate for managing ... LX1032 is designed to reduce serotonin production in patients ...
    ... The Leukemia & Lymphoma Society (LLS) and The ... initiative to develop stable and immortalized Waldenstrom,s macroglobulinemia (WM) ... researchers to test potential new treatments for the disease. ... lymphoma, characterized by B-lymphocytes in the bone marrow, and ...
    Cached Biology Technology:China Clean Energy Provides Business Update 2China Clean Energy Provides Business Update 3Lexicon Initiates Phase 2 Clinical Trial of LX1032 in Patients With Carcinoid Syndrome 2Lexicon Initiates Phase 2 Clinical Trial of LX1032 in Patients With Carcinoid Syndrome 3Lexicon Initiates Phase 2 Clinical Trial of LX1032 in Patients With Carcinoid Syndrome 4The Leukemia & Lymphoma Society and The International Waldenstrom's Macroglobulinemia Foundation Partner to Develop Cell Lines to Advance Research 2The Leukemia & Lymphoma Society and The International Waldenstrom's Macroglobulinemia Foundation Partner to Develop Cell Lines to Advance Research 3
    ... a fixative useful for routine procedures. Hollandes ... stable and will decalcify small bone specimens. ... be stained successfully with most stains, and ... red blood cell membranes and cosinophil and ...
    Chicken polyclonal antibody to Glutathione-S-Transfrease (GST)...
    ... the complete enterprise microarray informatics platform for microarray ... Acuity once and use it forever without paying ... Quality Acuity has all the analysis tools ... data, from quality control statistics and normalization, all ...
    ... As the world of discovery races ever ... you on the fast track. So our constant ... help accelerate your research. Thats why our Biomek ... platform thats as advanced as it is flexible. ...
    Biology Products: